What's the Difference Between 2.5 mg and 5 mg Mounjaro?

Mounjaro is a once-weekly injectable medicine whose active substance, tirzepatide, acts on both GLP-1 and GIP receptors — pathways involved in appetite regulation and the feeling of fullness. According to the electronic Medicines Compendium (eMC), Mounjaro is started at 2.5 mg once weekly, with dose increases made in steps under prescriber supervision. The 5 mg dose is the first increase after the initial period at 2.5 mg.

Why start at 2.5 mg?

The lower starting dose is not a therapeutic target — it is primarily intended to help your body acclimatise to the medicine and reduce the likelihood of gastrointestinal side effects such as nausea, vomiting, and diarrhoea, which are commonly reported in the early weeks. Many people find these effects ease as they settle into their dose.

What changes at 5 mg?

At 5 mg, the medicine remains the same tirzepatide compound; the increase simply means more of it is delivered per weekly dose. Some people notice a stronger reduction in appetite or "food noise" at this stage, while others experience a renewed period of adjustment with side effects. Individual responses vary considerably — there is no single pattern that applies to everyone.

How does this compare to other weight-loss injections?

Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, which distinguishes it from Wegovy (semaglutide), a GLP-1 receptor agonist only. Both are prescription-only, once-weekly injectable medicines that work on appetite-regulating pathways, but they have different active substances, different dose strengths, and different titration schedules. For a fuller factual overview, see our guide on the key differences between Wegovy and Mounjaro, or our broader look at how the main weight-loss injections compare. All decisions about which medicine is right for you belong with your prescriber.

It is also worth noting that Mounjaro carries a black triangle (▼) designation, meaning it is subject to additional monitoring. If you experience side effects, report them to your healthcare professional and to your national pharmacovigilance scheme (such as the UK Yellow Card scheme, if you are based there).

One of the most practically useful things you can do across any dose stage is keep a clear log — and that is exactly where GLP Trackr helps. The app's dose logging feature lets you record each injection: the dose strength, the date, and the time, so you always have an accurate picture of where you are in your schedule. When you move from 2.5 mg to 5 mg (or any subsequent stage), updating your log takes seconds and your history stays intact.

Alongside dose logging, the side-effect tracker lets you note how you feel at each stage — useful when the 2.5 mg-to-5 mg transition brings a fresh wave of nausea or fatigue. Patterns recorded over days and weeks become genuinely helpful to bring to your next prescriber appointment, giving them real context rather than your best recollection.

GLP Trackr also supports both Mounjaro and Wegovy users. If you are curious about how tracking works across the two medicines, our overview of Wegovy vs Mounjaro covers the key factual differences, and you can find more detail in our comparison of what sets Wegovy and Mounjaro apart.

Any question about whether — or when — to move between doses should be directed to your prescriber or doctor. GLP Trackr helps you record your experience so you can have a more informed conversation with them; it is not a substitute for their clinical guidance.

Ready to keep a clear record of every dose, side effect, and step forward? Download GLP Trackr on the App Store or Google Play and start a free 7-day trial.